Singapore markets closed
Straits Times Index
3,323.20 -6.89 (-0.21%) S&P 500
5,306.04 +1.32 (+0.02%) Dow
38,852.86 -216.74 (-0.55%) Nasdaq
17,019.88 +99.08 (+0.59%) Bitcoin USD
67,861.99 -628.49 (-0.92%) CMC Crypto 200
1,462.91 -21.78 (-1.47%)
Verrica Pharmaceuticals Inc. (VRCA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 8.56 |
| Open | 8.55 |
| Bid | 8.40 x 200 |
| Ask | 8.48 x 100 |
| Day's range | 8.20 - 8.76 |
| 52-week range | 2.86 - 11.41 |
| Volume | |
| Avg. volume | 191,691 |
| Market cap | 357.177M |
| Beta (5Y monthly) | 1.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Explore Verrica Pharmaceuticals' financial performance, strategic partnerships, and operational insights from the first quarter of 2024.
- GuruFocus.com
Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review
Exploring Verrica's Financial Outcomes and Strategic Developments in the First Quarter
- Zacks
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
Verrica Pharmaceuticals (VRCA) delivered earnings and revenue surprises of 29.63% and 41.97%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.